BN Business News
Add your company to Business Communicator →

Energy & environment · 08/12/2022Updated: 10/17/2026 · 1 min read

U.S. Nuclear Regulatory Commission Approves SHINE Medical Technologies' Request to Amend Construction Permit for Isotope Production Facility

Summary

The U.S. Nuclear Regulatory Commission has approved SHINE Medical Technologies' request to extend the completion deadline for the SHINE Medical Isotope Production Facility in Wisconsin from December 31, 2022, to December 31, 2025, and change the permit holder's name to SHINE Technologies, LLC.

Original source language: Federal Register — Nuclear Regulatory CommissionOpen original release →

Explore insights

Business insights →